Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ruiz-Morales ER"'
Autor:
Chen R; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Lukianova E; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., van der Loeff IS; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK., Spegarova JS; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Willet JDP; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., James KD; Institute of Immunology and Immunotherapy, University of Birmingham. B15 2TT Birmingham, UK., Ryder EJ; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Griffin H; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., IJspeert H; Department of Immunology, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands., Gajbhiye A; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Lamoliatte F; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Marin-Rubio JL; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Woodbine L; Genome Damage and Stability Centre, University of Sussex, BN1 9RQ Brighton, UK., Lemos H; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Swan DJ; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Pintar V; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Sayes K; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Ruiz-Morales ER; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Eastham S; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Dixon D; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Prete M; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Prigmore E; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Jeggo P; Genome Damage and Stability Centre, University of Sussex, BN1 9RQ Brighton, UK., Boyes J; Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, UK., Mellor A; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Huang L; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., van der Burg M; Department of Immunology, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands., Engelhardt KR; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Stray-Pedersen A; Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo 0424, Norway., Erichsen HC; Division of Pediatric and Adolescent Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo 0424, Norway., Gennery AR; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK., Trost M; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK., Adams DJ; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Anderson G; Institute of Immunology and Immunotherapy, University of Birmingham. B15 2TT Birmingham, UK., Lorenc A; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Trynka G; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.; Open Targets, Wellcome Genome Campus, CB10 1SA Hinxton, UK., Hambleton S; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK.
Publikováno v:
Science immunology [Sci Immunol] 2024 May 24; Vol. 9 (95), pp. eade5705. Date of Electronic Publication: 2024 May 24.
Autor:
Hoo R; Wellcome Sanger Institute, Cambridge, UK; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK., Ruiz-Morales ER; Wellcome Sanger Institute, Cambridge, UK., Kelava I; Wellcome Sanger Institute, Cambridge, UK., Rawat M; Wellcome Sanger Institute, Cambridge, UK; Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, UK., Mazzeo CI; Wellcome Sanger Institute, Cambridge, UK., Tuck E; Wellcome Sanger Institute, Cambridge, UK., Sancho-Serra C; Wellcome Sanger Institute, Cambridge, UK., Chelaghma S; Department of Biochemistry, University of Cambridge, Cambridge, UK., Predeus AV; Wellcome Sanger Institute, Cambridge, UK., Murray S; Wellcome Sanger Institute, Cambridge, UK., Fernandez-Antoran D; Wellcome/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK., Waller RF; Department of Biochemistry, University of Cambridge, Cambridge, UK., Álvarez-Errico D; IMIDomics, Inc., Barcelona, Spain., Lee MCS; Wellcome Sanger Institute, Cambridge, UK; Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, UK. Electronic address: mlee001@dundee.ac.uk., Vento-Tormo R; Wellcome Sanger Institute, Cambridge, UK; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK. Electronic address: rv4@sanger.ac.uk.
Publikováno v:
Cell systems [Cell Syst] 2024 May 15; Vol. 15 (5), pp. 425-444.e9. Date of Electronic Publication: 2024 May 03.
Autor:
Arutyunyan A; Wellcome Sanger Institute, Cambridge, UK.; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK., Roberts K; Wellcome Sanger Institute, Cambridge, UK., Troulé K; Wellcome Sanger Institute, Cambridge, UK., Wong FCK; Wellcome Sanger Institute, Cambridge, UK., Sheridan MA; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Kats I; Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Garcia-Alonso L; Wellcome Sanger Institute, Cambridge, UK., Velten B; Wellcome Sanger Institute, Cambridge, UK.; Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hoo R; Wellcome Sanger Institute, Cambridge, UK., Ruiz-Morales ER; Wellcome Sanger Institute, Cambridge, UK., Sancho-Serra C; Wellcome Sanger Institute, Cambridge, UK., Shilts J; Wellcome Sanger Institute, Cambridge, UK., Handfield LF; Wellcome Sanger Institute, Cambridge, UK., Marconato L; Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany., Tuck E; Wellcome Sanger Institute, Cambridge, UK., Gardner L; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Mazzeo CI; Wellcome Sanger Institute, Cambridge, UK., Li Q; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Kelava I; Wellcome Sanger Institute, Cambridge, UK., Wright GJ; Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, York, UK., Prigmore E; Wellcome Sanger Institute, Cambridge, UK., Teichmann SA; Wellcome Sanger Institute, Cambridge, UK.; Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK., Bayraktar OA; Wellcome Sanger Institute, Cambridge, UK. ob5@sanger.ac.uk., Moffett A; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK. am485@cam.ac.uk.; Department of Pathology, University of Cambridge, Cambridge, UK. am485@cam.ac.uk., Stegle O; Wellcome Sanger Institute, Cambridge, UK. oliver.stegle@embl.de.; Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany. oliver.stegle@embl.de.; European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany. oliver.stegle@embl.de., Turco MY; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK. margherita.turco@fmi.ch.; Department of Pathology, University of Cambridge, Cambridge, UK. margherita.turco@fmi.ch.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. margherita.turco@fmi.ch., Vento-Tormo R; Wellcome Sanger Institute, Cambridge, UK. rv4@sanger.ac.uk.; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK. rv4@sanger.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7955), pp. 143-151. Date of Electronic Publication: 2023 Mar 29.
Autor:
Nakatani T; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Lin J; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Ji F; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Ettinger A; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Pontabry J; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Tokoro M; Faculty of Biology-Oriented Science and Technology, Kindai University, Wakayama, Japan., Altamirano-Pacheco L; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Fiorentino J; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany.; Institute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany., Mahammadov E; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany.; Institute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany., Hatano Y; Faculty of Biology-Oriented Science and Technology, Kindai University, Wakayama, Japan., Van Rechem C; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA, USA., Chakraborty D; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA, USA., Ruiz-Morales ER; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Arguello Pascualli PY; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Scialdone A; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany.; Institute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany., Yamagata K; Faculty of Biology-Oriented Science and Technology, Kindai University, Wakayama, Japan., Whetstine JR; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA, USA.; Cancer Signaling and Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Sadreyev RI; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Torres-Padilla ME; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany. torres-padilla@helmholtz-muenchen.de.; Faculty of Biology, Ludwig-Maximilians Universität, München, Germany. torres-padilla@helmholtz-muenchen.de.
Publikováno v:
Nature genetics [Nat Genet] 2022 Mar; Vol. 54 (3), pp. 318-327. Date of Electronic Publication: 2022 Mar 07.
Autor:
Iturbide A; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Ruiz Tejada Segura ML; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Institute of Functional Epigenetics (IFE), Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, Germany., Noll C; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Schorpp K; Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany., Rothenaigner I; Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany., Ruiz-Morales ER; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Lubatti G; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Institute of Functional Epigenetics (IFE), Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, Germany., Agami A; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Hadian K; Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany., Scialdone A; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Institute of Functional Epigenetics (IFE), Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, Germany., Torres-Padilla ME; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany. torres-padilla@helmholtz-muenchen.de.; Faculty of Biology, Ludwig-Maximilians Universität, Munich, Germany. torres-padilla@helmholtz-muenchen.de.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2022 Mar; Vol. 29 (3), pp. 282.
Autor:
Rodríguez M; Laboratorio Nacional para la Producción y Análisis de Moléculas y Medicamentos Biotecnológicos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico., Castro-Acosta RM; Laboratorio Nacional para la Producción y Análisis de Moléculas y Medicamentos Biotecnológicos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico., Ruiz-Morales ER; Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico., Villanueva-Flores F; Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico., Ramírez OT; Laboratorio Nacional para la Producción y Análisis de Moléculas y Medicamentos Biotecnológicos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico.; Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico., Palomares LA; Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, CP 62210, Cuernavaca, Morelos, Mexico. laura@ibt.unam.mx.
Publikováno v:
Biotechnology letters [Biotechnol Lett] 2021 Jun; Vol. 43 (6), pp. 1155-1161. Date of Electronic Publication: 2021 Feb 27.
Autor:
Iturbide A; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Ruiz Tejada Segura ML; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Institute of Functional Epigenetics (IFE), Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, Germany., Noll C; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Schorpp K; Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany., Rothenaigner I; Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany., Ruiz-Morales ER; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Lubatti G; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Institute of Functional Epigenetics (IFE), Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, Germany., Agami A; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Hadian K; Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany., Scialdone A; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Institute of Functional Epigenetics (IFE), Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, Germany., Torres-Padilla ME; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany. torres-padilla@helmholtz-muenchen.de.; Faculty of Biology, Ludwig-Maximilians Universität, Munich, Germany. torres-padilla@helmholtz-muenchen.de.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2021 Jun; Vol. 28 (6), pp. 521-532. Date of Electronic Publication: 2021 May 27.
Autor:
Burton A; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Brochard V; Université Paris-Saclay, INRAE, ENVA, BREED U1198, Jouy-en-Josas, France., Galan C; Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.; Inmunologia y Genetica Aplicada, Madrid, Spain., Ruiz-Morales ER; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Rovira Q; Max Planck Institute for Molecular Biomedicine, Münster, Germany., Rodriguez-Terrones D; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany., Kruse K; Max Planck Institute for Molecular Biomedicine, Münster, Germany., Le Gras S; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM U964, CU de Strasbourg, France., Udayakumar VS; New England Biolabs, Ipswich, MA, USA., Chin HG; New England Biolabs, Ipswich, MA, USA., Eid A; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany.; The Francis Crick Institute, London, UK., Liu X; Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China., Wang C; Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China., Gao S; Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China., Pradhan S; New England Biolabs, Ipswich, MA, USA., Vaquerizas JM; Max Planck Institute for Molecular Biomedicine, Münster, Germany.; MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK., Beaujean N; Université Paris-Saclay, INRAE, ENVA, BREED U1198, Jouy-en-Josas, France.; Université Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron, France., Jenuwein T; Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany., Torres-Padilla ME; Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, München, Germany. torres-padilla@helmholtz-muenchen.de.; Faculty of Biology, Ludwig Maximilians University, Munich, Germany. torres-padilla@helmholtz-muenchen.de.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2020 Jul; Vol. 22 (7), pp. 767-778. Date of Electronic Publication: 2020 Jun 29.
Autor:
Borsos M; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.; Faculty of Biology, Ludwig-Maximilians Universität, Munich, Germany., Perricone SM; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Schauer T; Bioinformatics Unit, Biomedical Center, Ludwig-Maximilians-University, Planegg, Martinsried, Germany., Pontabry J; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., de Luca KL; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., de Vries SS; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Ruiz-Morales ER; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany., Torres-Padilla ME; Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany. torres-padilla@helmholtz-muenchen.de.; Faculty of Biology, Ludwig-Maximilians Universität, Munich, Germany. torres-padilla@helmholtz-muenchen.de., Kind J; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. j.kind@hubrecht.eu.
Publikováno v:
Nature [Nature] 2019 May; Vol. 569 (7758), pp. 729-733. Date of Electronic Publication: 2019 May 22.